Jovian Yu
-
- Immune Cell Function and Interaction 4
-
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 4
-
- Lymphoma Diagnosis and Treatment 4
-
- Chronic Lymphocytic Leukemia Research 3
- Glioma Diagnosis and Treatment 2
-
- SARS-CoV-2 and COVID-19 Research 2
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Thomas F. GajewskiRobin ReschkeKen HatogaiEmily F. HiggsBlake FloodJames GodfreyJustin KlineSherin J. Rouhani
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Jovian Yu
22 papers receiving 501 citations
Peers
Comparison fields: 5 of 72
- Immunology 216
- Oncology 232
- Cancer Research 61
- Hematology 43
- Molecular Biology 173
Countries citing papers authored by Jovian Yu
This map shows the geographic impact of Jovian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jovian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jovian Yu more than expected).
Fields of papers citing papers by Jovian Yu
This network shows the impact of papers produced by Jovian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jovian Yu. The network helps show where Jovian Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jovian Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 10 | |
| 3 | 2023 | 13 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 62 | |
| 7 | 2022 | 31 | |
| 8 | 2022 | 105 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 15 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 98 | |
| 14 | 2021 | 3 | |
| 15 | 2017 | 1 | |
| 16 | 2016 | 2 | |
| 17 | 2016 | 66 | |
| 18 | 2016 | 1 | |
| 19 | 2014 | 52 | |
| 20 | 2011 | 10 |
About Jovian Yu
Jovian Yu is a scholar working on Leadership and Management, Genetics and Oncology, having authored 25 papers that have together received 506 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Immunology (216 citations), Oncology (232 citations) and Cancer Research (61 citations). Jovian Yu has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Thomas F. Gajewski, Robin Reschke, Ken Hatogai, Emily F. Higgs, Blake Flood, James Godfrey, Justin Kline, Sherin J. Rouhani, Robbert M. Spaapen and Douglas E. Kline. Their work appears in journals such as Journal of Clinical Oncology, Blood and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.